TABLE OF CONTENTS
Volume 68, Issue 3 (September 2005)
Perspectives in Renal Medicine |
Perspectives in Basic Science |
Genetic Disorders – Development |
Hormones – Cytokines – Signaling |
Cell Biology – Immunology – Pathology |
Ion Channels – Membrane Transport – Integrative Physiology |
Vascular Biology – Hemodynamics – Hypertension |
Clinical Nephrology – Epidemiology – Clinical Trials |
Dialysis – Transplantation |
Editorials |
Letters to the Editor |
Nephrology Forum |
International Society of Nephrology
A Message to Our Reader
Changing of the Guard
JAN J WEENING M.D. ISN President and ERIC G NEILSON M.D. Chairman, ISN Publications Committee
Kidney Int 68: 913; doi:10.1111/j.1523-1755.2005.00544.x
Perspectives in Renal Medicine
Unraveling the racial disparities associated with kidney disease
KEITH C NORRIS and LAWRENCE Y AGODOA
Kidney Int 68: 914-924; doi:10.1111/j.1523-1755.2005.00485.x
See also: Editorial by PUGSLEYPerspectives in Basic Science
Obstructive nephropathy: Insights from genetically engineered animals
JEAN-LOUP BASCANDS and JOOST P SCHANSTRA
Kidney Int 68: 925-937; doi:10.1111/j.1523-1755.2005.00486.x
Genetic Disorders – Development
Aprt/Opn double knockout mice: Osteopontin is a modifier of kidney stone disease severity
HILARY J VERNON, CHRISTINE OSBORNE, ELENI G TZORTZAKI, MIN YANG, JIANMEN CHEN, SUSAN R RITTLING, DAVID T DENHARDT, STEVEN BUYSKE, SHARON B BLEDSOE, ANDREW P EVAN, LYNETTE FAIRBANKS, H ANNE SIMMONDS, JAY A TISCHFIELD and AMRIK SAHOTA
Kidney Int 68: 938-947; doi:10.1111/j.1523-1755.2005.00487.x
A comparative study of three kidney biomarker tests in autosomal-dominant polycystic kidney disease
J ANTONIO CASAL, JESÚS HERMIDA, XOSÉ M LENS and J CARLOS TUTOR
Kidney Int 68: 948-954; doi:10.1111/j.1523-1755.2005.00488.x
Mutagenesis of the epithelial polarity gene, discs large 1, perturbs nephrogenesis in the developing mouse kidney
EMAN NAIM, ALAN BERNSTEIN, JOHN F BERTRAM and GEORGINA CARUANA
Kidney Int 68: 955-965; doi:10.1111/j.1523-1755.2005.00489.x
Segregation of urine calcium excretion in families ascertained for nephrolithiasis: Evidence for a major gene
J C LOREDO-OSTI, NICOLE M ROSLIN, JOSÉE TESSIER, T MARY FUJIWARA, KENNETH MORGAN and ALAIN BONNARDEAUX
Kidney Int 68: 966-971; doi:10.1111/j.1523-1755.2005.00490.x
Hormones – Cytokines – Signaling
MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-
in rat mesangial cells
BAOLIANG GUO, KEN INOKI, MOTOHIDE ISONO, HIROYUKI MORI, KEIZO KANASAKI, TOSHIRO SUGIMOTO, SATOSHI AKIBA, TAKASHI SATO, BAOFENG YANG, RYUICHI KIKKAWA, ATSUNORI KASHIWAGI, MASAKAZU HANEDA and DAISUKE KOYA
Kidney Int 68: 972-984; doi:10.1111/j.1523-1755.2005.00491.x
High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule
SONIA SAAD, VERONICA A STEVENS, LESLEY WASSEF, PHILIP PORONNIK, DARREN J KELLY, RICHARD E GILBERT and CAROL A POLLOCK
Kidney Int 68: 985-997; doi:10.1111/j.1523-1755.2005.00492.x
Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism
PIERRE D'AMOUR, JEAN-HUGUES BROSSARD, LOUISE ROUSSEAU, LOAN NGUYEN-YAMAMOTO, EDGARD NASSIF, CLAUDE LAZURE, DANY GAUTHIER, JEFFREY R LAVIGNE and RICHARD J ZAHRADNIK
Kidney Int 68: 998-1007; doi:10.1111/j.1523-1755.2005.00493.x
Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C
ALEKSANDRA SINDI
, ANA VELIC, CANDAN BA
OGLU, JOCHEN R HIRSCH, BAYRAM EDEMIR, MICHAELA KUHN and EBERHARD SCHLATTER
Kidney Int 68: 1008-1017; doi:10.1111/j.1523-1755.2005.00518.x
See also: Editorial by BRUNEVAL et al.Cell Biology – Immunology – Pathology
Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice
MIZUHO KOBAYASHI, HITOSHI SUGIYAMA, DA-HONG WANG, NAOMI TODA, YOHEI MAESHIMA, YASUSHI YAMASAKI, NORIYOSHI MASUOKA, MASAO YAMADA, SHOHEI KIRA and HIROFUMI MAKINO
Kidney Int 68: 1018-1031; doi:10.1111/j.1523-1755.2005.00494.x
Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease
JENS STAHLSCHMIDT, CLAIRE L VARLEY, GILES TOOGOOD, PETER J SELBY and JENNIFER SOUTHGATE
Kidney Int 68: 1032-1040; doi:10.1111/j.1523-1755.2005.00495.x
Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat
BERNARDO RODRÍGUEZ-ITURBE, YASMIR QUIROZ, ASHKAN SHAHKARAMI, ZHEN LI and NOSRATOLA D VAZIRI
Kidney Int 68: 1041-1047; doi:10.1111/j.1523-1755.2005.00496.x
Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1–associated nephropathy
JIANYONG ZHONG, YIQIN ZUO, JI MA, AGNES B FOGO, PAUL JOLICOEUR, IEKUNI ICHIKAWA and TAIJI MATSUSAKA
Kidney Int 68: 1048-1060; doi:10.1111/j.1523-1755.2005.00497.x
Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis
JULIE ROBERTSON, JEAN WU, JON ARENDS, WILLIAM GLASS II, SCOTT SOUTHWOOD, ALESSANDRO SETTE and YA-HUAN LOU
Kidney Int 68: 1061-1070; doi:10.1111/j.1523-1755.2005.00498.x
Scanning ion conductance microscopy reveals how a functional renal epithelial monolayer maintains its integrity
YANJUN ZHANG, JULIA GORELIK, DANIEL SANCHEZ, ANDREW SHEVCHUK, MAX LAB, IGOR VODYANOY, DAVID KLENERMAN, CHRISTOPHER EDWARDS and YURI KORCHEV
Kidney Int 68: 1071-1077; doi:10.1111/j.1523-1755.2005.00499.x
Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN
YOSHIHARU NISHITANI, MASAYUKI IWANO, YUKINARI YAMAGUCHI, KOJI HARADA, KIMIHIKO NAKATANI, YASUHIRO AKAI, TOSHIHIKO NISHINO, HIDEO SHIIKI, MASAO KANAUCHI, YOSHIHIKO SAITO and ERIC G NEILSON
Kidney Int 68: 1078-1085; doi:10.1111/j.1523-1755.2005.00500.x
See also: Dialysis – Transplantation by CHANG et al.Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis
CHRISTIAN PLANK, ANDREA HARTNER, BERND KLANKE, BETTINA GEISSLER, MARKUS PORST, KERSTIN AMANN, KARL F HILGERS, WOLFGANG RASCHER and JÖRG DÖTSCH
Kidney Int 68: 1086-1095; doi:10.1111/j.1523-1755.2005.00501.x
Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney
XIANGYANG DONG, SUNDARARAMAN SWAMINATHAN, LORI A BACHMAN, ANTHONY J CROATT, KARL A NATH and MATTHEW D GRIFFIN
Kidney Int 68: 1096-1108; doi:10.1111/j.1523-1755.2005.00502.x
Podocyte involvement in human immune crescentic glomerulonephritis
JEAN BARIÉTY, PATRICK BRUNEVAL, ALAIN MEYRIER, CHANTAL MANDET, GARY HILL and CHRISTIAN JACQUOT
Kidney Int 68: 1109-1119; doi:10.1111/j.15231755.2005.00503.x
Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?
STEPHEN R BATSFORD, SERGIO MEZZANO, MICHAEL MIHATSCH, EMILE SCHILTZ and BERNARDO RODRÍGUEZ-ITURBE
Kidney Int 68: 1120-1129; doi:10.1111/j.1523-1755.2005.00504.x
Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue
MARINA HAIMAN, WILLI SALVENMOSER, KARL SCHEIBER, ARNO LINGENHEL, CHRISTIAN RUDOLPH, GERD SCHMITZ, FLORIAN KRONENBERG and HANS DIEPLINGER
Kidney Int 68: 1130-1136; doi:10.1111/j.1523-1755.2005.00519.x
Ion Channels – Membrane Transport – Integrative Physiology
Role of membrane microdomains in PTH-mediated down-regulation of NaPi-IIa in opossum kidney cells
KUNITAKA NASHIKI, YUTAKA TAKETANI, TOMOKO TAKEICHI, NAOKI SAWADA, HIRONORI YAMAMOTO, MASAKO ICHIKAWA, HIDEKAZU ARAI, KEN-ICHI MIYAMOTO and EIJI TAKEDA
Kidney Int 68: 1137-1147; doi:10.1111/j.1523-1755.2005.00505.x
Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules
MICHEL BAUM, SUSAN SCHIAVI, VANGIPURAM DWARAKANATH and RAYMOND QUIGLEY
Kidney Int 68: 1148-1153; doi:10.1111/j.1523-1755.2005.00506.x
Vascular Biology – Hemodynamics – Hypertension
Racial differences in renal arteriolar structure in children with minimal change nephropathy
STEPHEN G ROSTAND, SARITA K CROSS, KATHARINE A KIRK, JEANNETTE Y LEE, ALEXANDER KUHLMANN and KERSTIN AMANN
Kidney Int 68: 1154-1160; doi:10.1111/j.1523-1755.2005.00507.x
Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis
VALENTINA VANEGAS, ATILIO FERREBUZ, YASMIR QUIROZ and BERNARDO RODRÍGUEZ-ITURBE
Kidney Int 68: 1161-1170; doi:10.1111/j.1523-1755.2005.00508.x
Differential connexin expression in preglomerular and postglomerular vasculature: Accentuation during diabetes
JIANHONG ZHANG and CARYL E HILL
Kidney Int 68: 1171-1185; doi:10.1111/j.1523-1755.2005.00509.x
Clinical Nephrology – Epidemiology – Clinical Trials
Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease
VEENA RAIZADA, BETTY SKIPPER, WENTAO LUO, LUIS GARZA, CURT W HINES, ANTONIA A HARFORD, PHILIP G ZAGER, JEFFREY GRIFFITH, DOMINIC RAJ and CHARLES T SPALDING
Kidney Int 68: 1186-1189; doi:10.1111/j.1523-1755.2005.00510.x
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
KASPER ROSSING, KATRINE J SCHJOEDT, BERIT R JENSEN, FRANS BOOMSMA and HANS-HENRIK PARVING
Kidney Int 68: 1190-1198; doi:10.1111/j.1523-1755.2005.00511.x
Predictors of survival in anuric peritoneal dialysis patients
MAARTEN A M JANSEN, FABIAN TERMORSHUIZEN, JOHANNA C KOREVAAR, FRIEDO W DEKKER, ELISABETH BOESCHOTEN and RAYMOND T KREDIET FOR THE NECOSAD STUDY GROUP
Kidney Int 68: 1199-1205; doi:10.1111/j.1523-1755.2005.00512.x
Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry
GABRIELE LEHMANN, GÜNTER STEIN, MANFRED HÜLLER, RUDOLF SCHEMER, KASTOORIRANGANATHAN RAMAKRISHNAN and WILLIAM G GOODMAN
Kidney Int 68: 1206-1214; doi:10.1111/j.1523-1755.2005.00513.x
Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients
AANTJE V KHARAGJITSINGH, JOKE C KOREVAAR, JAN P VANDENBROUCKE, ELISABETH W BOESCHOTEN, RAYMOND T KREDIET, MOHAMMED R DAHA and FRIEDO W DEKKER THE NECOSAD STUDY GROUP
Kidney Int 68: 1215-1222; doi:10.1111/j.1523-1755.2005.00514.x
In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis
DANIELA MOLINO, DOMENICO DE LUCIA, ROSA MAROTTA, ALESSANDRA PERNA, CINZIA LOMBARDI, MASSIMO CIRILLO and NATALE GASPARE DE SANTO
Kidney Int 68: 1223-1229; doi:10.1111/j.1523-1755.2005.00515.x
Diabetes mellitus and the risk of nephrolithiasis
ERIC N TAYLOR, MEIR J STAMPFER and GARY C CURHAN
Kidney Int 68: 1230-1235; doi:10.1111/j.1523-1755.2005.00516.x
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl
KEVIN J MARTIN, HARALD JÜPPNER, DONALD J SHERRARD, WILLIAM G GOODMAN, MARK R KAPLAN, GEORGE NASSAR, PATRICIA CAMPBELL, MARIO CURZI, CHAIM C HARYTAN, LAURA C MCCARY, MATTHEW D GUO, STEWART A TURNER and DAVID A BUSHINSKY
Kidney Int 68: 1236-1243; doi:10.1111/j.1523-1755.2005.00517.x
Use of a probioitic to decrease enteric hyperoxaluria
JOHN C LIESKE, DAVID S GOLDFARB, CLAUDIO DE SIMONE and CYNTHIA REGNIER
Kidney Int 68: 1244-1249; doi:10.1111/j.1523-1755.2005.00520.x
Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study
ANNE SOFIE ASTRUP, LISE TARNOW, PETER ROSSING, LOTTE PIETRASZEK, PETER RIIS HANSEN and HANS-HENRIK PARVING
Kidney Int 68: 1250-1257; doi:10.1111/j.1523-1755.2005.00521.x
Progression of coronary artery calcification in diabetics with and without chronic kidney disease
RAJNISH MEHROTRA, MATTHEW BUDOFF, JOHN E HOKANSON, ELI IPP, JUNICHIRO TAKASU and SHARON ADLER
Kidney Int 68: 1258-1266; doi:10.1111/j.1523-1755.2005.00522.x
Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes
MEDA E PAVKOV, PETER H BENNETT, MAURICE L SIEVERS, JONATHAN KRAKOFF, DESMOND E WILLIAMS, WILLIAM C KNOWLER and ROBERT G NELSON
Kidney Int 68: 1267-1274; doi:10.1111/j.1523-1755.2005.00523.x
High incidence of initial and late steroid resistance in childhood nephrotic syndrome
JUNG SUE KIM, CHRISTINE A BELLEW, DOUGLAS M SILVERSTEIN, DIEGO H AVILES, FRANK G BOINEAU and V MATTI VEHASKARI
Kidney Int 68: 1275-1281; doi:10.1111/j.1523-1755.2005.00524.x
Factors associated with "do not resuscitate" orders and rates of withdrawal from hemodialysis in the international DOPPS
RACHEL B FISSELL, JENNIFER L BRAGG-GRESHAM, ANTONIO ALBERTO LOPES, JOSÉ MIGUEL CRUZ, SHUNICHI FUKUHARA, YASUSHI ASANO, WENDY WEINSTOCK BROWN, MARCIA L KEEN, FRIEDRICH K PORT and ERIC W YOUNG
Kidney Int 68: 1282-1288; doi:10.1111/j.1523-1755.2005.00525.x
Albuminuria and incident coronary heart disease in Australian Aboriginal people
ZHIQIANG WANG and WENDY E HOY
Kidney Int 68: 1289-1293; doi:10.1111/j.1523-1755.2005.00526.x
Dialysis – Transplantation
Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events–free hemodialysis patients
GIOVANNI TRIPEPI, RICCARDO MARIA FAGUGLI, PIETRO DATTOLO, GIOVANNA PARLONGO, FRANCESCA MALLAMACI, UMBERTO BUONCRISTIANI and CARMINE ZOCCALI
Kidney Int 68: 1294-1302; doi:10.1111/j.1523-1755.2005.00527.x
3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis
MARINA PENÉLOPE CATALAN, BEATRIZ SANTAMARÍA, ANA REYERO, ARTURO ORTIZ, JESÚS EGIDO and ALBERTO ORTIZ
Kidney Int 68: 1303-1311; doi:10.1111/j.1523-1755.2005.00528.x
Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity
CHI-JEN CHANG, YU-SHIEN KO, PO-JEN KO, LUNG-AN HSU, CHIN-FEN CHEN, CHIH-WEI YANG, TSU-SHIU HSU and JONG-HWEIS PANG
Kidney Int 68: 1312-1319; doi:10.1111/j.1523-1755.2005.00529.x
See also: Cell Biology – Immunology – Pathology by NISHITANI et al.Parameters derived by ultrasonic myocardial characterization in dialysis patients are associated with mortality
FRANCESCO PIZZARELLI, PIETRO DATTOLO, EZIO MARIA FERDEGHINI and MARIA AURORA MORALES
Kidney Int 68: 1320-1325; doi:10.1111/j.1523-1755.2005.00530.x
Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats
TAKATOSHI KAKUTA, REIKA TANAKA, YOSHINOBU SATOH, YUKO IZUHARA, REIKO INAGI, MASAOMI NANGAKU, AKIRA SAITO and TOSHIO MIYATA
Kidney Int 68: 1326-1336; doi:10.1111/j.1523-1755.2005.00531.x
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin
STEVEN FISHBANE and JEFFREY S BERNS
Kidney Int 68: 1337-1343; doi:10.1111/j.1523-1755.2005.00532.x
The online measurement of hemodialysis dose (Kt): Clinical outcome as a function of body surface area
EDMUND G LOWRIE, ZHENSHENG LI, NORMA OFSTHUN and J MICHAEL LAZARUS
Kidney Int 68: 1344-1354; doi:10.1111/j.1523-1755.2005.00533.x
Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients
FUMIKI YOSHIHARA, TAKESHI HORIO, SATOKO NAKAMURA, MASAYOSHI YOSHII, CHINAMI OGATA, HAJIME NAKAHAMA, TAKASHI INENAGA, KENJI KANGAWA and YUHEI KAWANO
Kidney Int 68: 1355-1363; doi:10.1111/j.1523-1755.2005.00534.x
Editorials
Racial and ethnic disparities in renal disease
DAVID PUGSLEY
Kidney Int 68: 1364-1365; doi:10.1111/j.1523-1755.2005.00545.x
See also: Perspectives in Renal Medicine by NORRIS & AGODOARenewal of FSP1: A marker of fibrogenesis on human renal biopsies
PATRICK BRUNEVAL, JEROME ROSSERT and JEAN BARIETY
Kidney Int 68: 1366-1367; doi:10.1111/j.1523-1755.2005.00546.x
See also: Hormones – Cytokines – Signaling by SINDI et al.
Letters to the Editor
Changes in the Composition of Carnitines in Hemodialysis Patients
YI-SHENG LIN, WU-CHANG YANG, TZEN-WEN CHEN and CHIH-CHING LIN
Kidney Int 68: 1368; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by REUTER et al.Reply from the Authors
STEPHANIE E REUTER, ALLAN M EVANS and GIANFRANCO FORNASINI
Kidney Int 68: 1368-1369; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by LIN et al.Albuminuria in patients with hepatitis C: Is inflammation the missing link?
CHIKE M NZERUE
Kidney Int 68: 1369-1370; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by LIANGPUNSAKUL & CHALASANIReply from the Authors
SUTHAT LIANGPUNSAKUL and NAGA CHALASANI
Kidney Int 68: 1370; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by NZERUERed blood cell deformability and diabetic nephropathy
NIELS H SCHUT
Kidney Int 68: 1370-1371; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by BROWN et al.Reply from the Authors
CLINTON D BROWN, HALIM S GHALI, ZONG H ZHAO, LORRAINE L THOMAS and ELI A FRIEDMAN
Kidney Int 68: 1371; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by SCHUTPostprocedural drop in hematocrit versus contrast-induced nephropathy: Eggs or chickens?
MING-YU LAI, CHIH-CHING LIN and WU-CHANG YANG
Kidney Int 68: 1371-1372; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by NIKOLSKY et al.Reply from the Authors
EUGENIA NIKOLSKY, ROXANA MEHRAN and GEORGE DANGAS
Kidney Int 68: 1372; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by LAI et al.PAI-1 in diabetic nephropathy
ALEXANDRE HERTIG, GAELLE PELLE and ERIC RONDEAU
Kidney Int 68: 1372-1373; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by NICHOLAS & HSUEHReply from the Authors
SUSANNE B NICHOLAS and WILLA A HSUEH
Kidney Int 68: 1373; doi:10.1111/j.1523-1755.2005.00536.x
See also: Letter to the Editor by HERTIG et al.Does fluvastatin really have an antioxidant effect in humans?
SOHJI NAGASE, AKI HIRAYAMA, ATSUSHI UEDA, KOUICHI HIRAYAMA, JUNJI TERAO and AKIO KOYAMA
Kidney Int 68: 1373-1374; doi:10.1111/j.1523-1755.2005.00536.x
C-reactive protein and coronary heart disease in hemodialyzed patients
VINCENZO SEPE, CARMELO LIBETTA, GABRIELLA ADAMO, MARIA G GIULIANO, GRAZIA SOCCIO and ANTONIO DAL CANTON
Kidney Int 68: 1374-1375; doi:10.1111/j.1523-1755.2005.00536.x
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction
NAOYUKI NAKAO, MAKOTO SAKAI, AKIRA FUJIMORI and MASFUMI FUKAGAWA
Kidney Int 68: 1375-1376; doi:10.1111/j.1523-1755.2005.00536.x
Nephrology Forum
Emerging treatment approaches for the systemic amyloidoses
LAURA M DEMBER Principal discussant:
Kidney Int 68: 1377-1390; doi:10.1111/j.1523-1755.2005.00535.x
International Society of Nephrology
MEETING ANNOUNCEMENTS
Kidney Int 68: 1392; doi:10.1111/j.1523-1755.2005.90683.x
